| Literature DB >> 23959110 |
Agata Serwatowska-Bargieł, Maria Wąsik, Maria Katarzyna Kornacka, Elżbieta Górska, Robert Kozarski.
Abstract
Preterm infants are very susceptible to infections. Immune response mechanisms in this group of patients and factors that influence cord blood mononuclear cell populations remain poorly understood and are considered insufficient. However, competent immune functions of the cord blood mononuclear cells are also described. The aim of this work was to evaluate the T-cell population (CD3+) with its subpopulations bearing T-cell receptor (TCR) αβ or TCR γδ in the cord blood of preterm infants born before 32 weeks of gestation by mothers with or without an intrauterine infection. Being a pilot study, it also aimed at feasibility check and assessment of an expected effect size. The cord blood samples of 46 infants age were subjected to direct immunofluorescent staining with monoclonal antibodies and then analyzed by flow cytometry. The percentage of CD3+ cells in neonates born by mothers with diagnosis of intrauterine infection was significantly lower than in neonates born by mothers without infection (p = 0.005; Mann–Whitney U test). The number of cells did not differ between groups. Infection present in the mother did not have an influence on the TCR αβ or TCR γδ subpopulations. Our study contributes to a better understanding of preterm infants’ immune mechanisms, and sets the stage for further investigations.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23959110 PMCID: PMC3898335 DOI: 10.1007/s00005-013-0244-z
Source DB: PubMed Journal: Arch Immunol Ther Exp (Warsz) ISSN: 0004-069X Impact factor: 4.291
Main characteristics of the studied groups
| Group I ( | Group II ( |
| Group Ia ( | Group Ib ( |
| |
|---|---|---|---|---|---|---|
| Gestational age (weeks) | ||||||
| Median (range) | 29 (24–31) | 30 (26–31) | 0.04 | 29 (25–31) | 28 (24–31) | NS |
| Birthweight (g) | ||||||
| Median (range) | 1,088 (640–1,650) | 1,460 (720–1,860) | 0.022 | 1,305 (640–1,560) | 1,020 (660–1,650) | NS |
| Sex M/F | ||||||
| Number (%) | 15/14 (51/49 %) | 8/9 (47/53 %) | NS | 6/8 (43/57 %) | 9/6 (60/40 %) | NS |
| Type of delivery V/C | ||||||
| Number (%) | 15/14 (51/49 %) | 3/14 (18/82 %) | 0.048 | 5/9 (36/64 %) | 10/5 (67/33 %) | NS |
| Antibiotic treatment of the mother | ||||||
| Number (%) | 24 (83 %) | 8 (47 %) | 0.027 | 12 (85 %) | 12 (80 %) | NS |
M male, F female, V vaginal delivery, C caesarian section, NS not significant
* Values assess the differences between the fractions
The percentages and numbers of CD3+ and subpopulations CD3+ TCR αβ and CD3+ TCR γδ in the studied groups of newborns
| Group I | Group II |
| Group Ia | Group Ib |
| |
|---|---|---|---|---|---|---|
| CD3+ /mm3 | 1,856 (1,488–2,266) | 1,838 (1,326–2,427) | NS | 1,895 (1,353–2,250) | 1,804 (1,525–2,518) | NS |
| CD3+ %a | 44 (32.4–51.4) | 52.6 (42.2–64.2) | 0.005 | 45.3 (36.7–52.1) | 43 (20.7–65) | NS |
| CD3+ αβ /mm3 | 1,730 (1,355–2,188) | 1,713 (1,071–2,216) | NS | 1,818 (968–1,900) | 1,699 (1,432–2,308) | NS |
| CD3+ αβ %b | 92 (87–96) | 92 (90–94) | NS | 89 (82.5–96.5) | 92 (89–95) | NS |
| CD3+ γδ /mm3 | 38 (24–60) | 38 (22–52) | NS | 33 (23–69) | 50 (38–59) | NS |
| CD3+ γδ %b | 2.1 (1.5–3) | 1.9 (1.5–2.5) | NS | 1.8 (1.1–3.2) | 2.4 (1.9–2.7) | NS |
Group I: neonates of mothers with intrauterine infection, in this Group Ia: neonates without signs of infection, Group Ib: neonates with diagnosed infection, Group II: neonates of mothers without infection
Me median, NS not significant
aOf all lymphocytes
bOf CD3+ lymphocytes
Fig. 1Percentage (a) and number (b) of CD3+ cells in cord blood of studied neonates. Group I—neonates of mothers with intrauterine infection, in this Group Ia—neonates without signs of infection, Group Ib—neonates with diagnosed infection, Group II—neonates of mothers without infection
Fig. 2Percentage (a) and number (b) of CD3+ TCR αβ cells in cord blood of studied neonates. Group I—neonates of mothers with intrauterine infection, in this Group Ia—neonates without signs of infection, Group Ib—neonates with diagnosed infection, Group II—neonates of mothers without infection
Fig. 3Percentage (a) and number (b) of CD3+ TCR γδ cells in cord blood of studied neonates. Group I—neonates of mothers with intrauterine infection, in this Group Ia—neonates without signs of infection, Group Ib—neonates with diagnosed infection, Group II—neonates of mothers without infection